Results 271 to 280 of about 15,878,608 (386)

Penalised regression improves imputation of cell-type specific expression using RNA-seq data from mixed cell populations compared to domain-specific methods. [PDF]

PLoS Comput Biol
Lin WY, Kartawinata M, Jebson BR, Restuadi R, Peckham H, Radziszewska A, Deakin CT, Ciurtin C, CLUSTER Consortium, Wedderburn LR, Wallace C.   +10 more
europepmc   +1 more source

Telomere biology and metabolic disorders: the role of insulin resistance and type 2 diabetes

, 2020
Е. N. Dudinskaya, О. Н. Ткачева, Н. В. Браилова, И. Д. Стражеско, Marina V. Shestakova   +4 more
openalex   +2 more sources

Supplementary Data for Newman JRB, Long A, Speake C, Greenbaum CJ, Cerosaletti K, Rich SS, Onengut-Gumuscu S, McIntyre LM, Buckner JH, Concannon P, "Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes", submitted to Communications Biology

, 2023
Jeremy R. B. Newman, Alice Long, Cate Speake, Carla J. Greenbaum, Karen Cerosaletti, Stephen S. Rich, Suna Onengut-Gomuscu, Lauren M. McIntyre, Patrick Concannon   +8 more
openalex   +2 more sources

Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer

Molecular Oncology, EarlyView.
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti, Shingo Inagaki, Tuyen Thuy Bich Ho, Akihiro Seki, Keiko Yoshida, Kosuke Satomura, Yoshio Sakai, Shuichi Kaneko, Taro Yamashita   +8 more
wiley   +1 more source

Publisher Correction: Transcriptional dynamics in type 2 diabetes progression is linked with circadian, thermogenic, and cellular stress in human adipose tissue. [PDF]

Commun Biol
Rivera-Alvarez I, Vázquez-Lizárraga R, Mendoza-Viveros L, Sotelo-Rivera I, Viveros-Ruiz TL, Morales-Maza J, Orozco L, Romano MC, Noriega LG, Tovar AR, Aguilar-Arnal L, Cruz-Bautista I, Aguilar-Salinas C, Orozco-Solis R.   +13 more
europepmc   +1 more source

The Utilization of Various Plant Type by the Community of Gunung Bunder Dua Village, Bogor Regency as a Resource of Biology Learning Process

, 2020
Rizna Akmaliyah, Wardah Wardah, Tri Cahyanto, Apriani Krisdianti, Deasy Rahmawati   +4 more
openalex   +2 more sources

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

Molecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia, Anouk C. de Jong, Lisanne F. van Dessel, Vanja de Weerd, Corine Beaufort, Jean Helmijr, José Alberto Nakauma‐González, Job van Riet, Paul Hamberg, Daniel Vis, Michiel S. van der Heijden, Nick Beije, Martijn P. Lolkema, Teoman Deger, Saskia M. Wilting, Ronald de Wit, Maurice P. H. M. Jansen, John W. M. Martens   +17 more
wiley   +1 more source

Evolution of cellular architecture and function of the hippocampus: insights from the artificial selection experiment. [PDF]

Biol Lett
Goncerzewicz A, Bonda-Ostaszewska E, Lipiec M, Knapska E, Konarzewski M.   +4 more
europepmc   +1 more source

Integration of single‐cell and bulk RNA‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer

Molecular Oncology, EarlyView.
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley   +1 more source

Novel non-synonymous and synonymous gene variants of SRD5A2 in patients with 46,XY-DSD and DSD-free subjects. [PDF]

PLoS One
Ramos L.
europepmc   +1 more source